title: An overview of intestine and multivisceral transplantation.
abstract: Intestine transplantation remains a formidable clinical and immunologic challenge. With newer immunosuppressive agents and accumulated experience, the survival outcomes for these patients are improving. The relationship of recipient preexisting conditions with the risk of postoperative events clearly emphasize the necessity of early referral of patients with intestinal failure to expert transplant program before the onset of life-threatening complications.30 With increased awareness and knowledge regarding referral criteria, transplant criteria, optimal time for transplantation, and medication regiments, improved patient outcomes after intestine and multivisceral transplant will be achieved.
authors: Abdominal Transplantation, UPMC Presbyterian, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA. paloms@upmc.edu
authors: Mary Sheela
authors: MS
authors: Palocaren
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007422:Intestines / Q000637:transplantation*; D011183:Postoperative Complications / Q000451:nursing; D014781:Viscera / Q000637:transplantation*
chemical_list: D007166:Immunosuppressive Agents